Status:

UNKNOWN

Open Study of the Neurobiological Effects of Intranasal Ketamine in Children and Adults With Bipolar Disorder

Lead Sponsor:

Mclean Hospital

Collaborating Sponsors:

Juvenile Bipolar Research Foundation

Conditions:

Bipolar Disorder

Eligibility:

All Genders

14-40 years

Brief Summary

Aim 1: Test the hypothesis that participants with Bipolar Disorder - Fear of Harm Phenotype have an enhanced amygdala fMRI response to fearful threatening stimuli, increased resting beta and gamma EEG...

Detailed Description

Clinically, the Fear of Harm phenotype is characterized by early age of onset, severe mood swings, treatment resistance, separation anxiety, fearful-aggressive obsessions, parasomnias (e.g. night-terr...

Eligibility Criteria

Inclusion

  • Males and Females
  • Age 14 - 40 years
  • Clinical diagnosis of Bipolar Disorder -Fear of Harm Phenotype
  • Meets Papolos criteria for FOH based on independent interviews.
  • Taking intranasal ketamine for at least 2 months.
  • Must be on an every three or every four-day dosing regimen
  • Dosage will not exceed 300 mg per dosing interval.
  • Willing to delay ketamine dose by 2 days past their prescribed dosing interval
  • Prior experience having tolerated this degree of delay.
  • Willing to participate in daily assessments during period of ketamine withdrawal prior to traveling to Belmont ,MA.
  • Willing to provide urine sample to screen for drugs of abuse (all participants and pregnancy in females.)

Exclusion

  • Any psychiatric hospitalization within the past 6 months
  • Lifetime history of suicide attempts
  • Co-occurring substance use disorders
  • Any change in concomitant medications within the last 2 months

Key Trial Info

Start Date :

June 4 2019

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 15 2023

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT05209217

Start Date

June 4 2019

End Date

January 15 2023

Last Update

January 27 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

McLean Hospital

Belmont, Massachusetts, United States, 02478